Bioatla Stock Performance
| BCAB Stock | USD 0.83 0.11 15.28% |
On a scale of 0 to 100, Bioatla holds a performance score of 6. The firm shows a Beta (market volatility) of -1.61, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bioatla are expected to decrease by larger amounts. On the other hand, during market turmoil, Bioatla is expected to outperform it. Please check Bioatla's maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to make a quick decision on whether Bioatla's price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Bioatla are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Bioatla sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin in Oropharyngeal Squamous Cell Carcinoma at the Annual Conference ... | 10/23/2025 |
2 | Can BioAtla Inc. stock sustain institutional interest - 2025 Big Picture Capital Protection Trade Alerts - Fundao Cultural do Par | 10/27/2025 |
3 | How supply chain issues affect BioAtla Inc. stock - Portfolio Gains Report Daily Technical Forecast Reports - newser.com | 11/06/2025 |
4 | Disposition of 12530 shares by Sievers Eric of Bioatla at 0.46 subject to Rule 16b-3 | 11/11/2025 |
5 | BioAtla Q3 2025 Earnings Call Transcript | 11/13/2025 |
6 | Disposition of 6347 shares by Jay Short of Bioatla at 0.409 subject to Rule 16b-3 | 11/14/2025 |
7 | BioAtla Inc. stock outlook for YEAR - 2025 Breakouts Breakdowns Safe Capital Allocation Plans - newser.com | 11/18/2025 |
8 | BioAtla Enters into Agreements for up to 22.5 Million Flexible Financing | 11/21/2025 |
9 | Disposition of 1566 shares by Christian Vasquez of Bioatla at 0.904 subject to Rule 16b-3 | 11/28/2025 |
10 | How rising interest rates impact BioAtla Inc. stock - 2025 Bull vs Bear Weekly Momentum Stock Picks - DonanmHaber | 12/19/2025 |
Bioatla Relative Risk vs. Return Landscape
If you would invest 69.00 in Bioatla on September 27, 2025 and sell it today you would earn a total of 14.00 from holding Bioatla or generate 20.29% return on investment over 90 days. Bioatla is currently generating 0.7697% in daily expected returns and assumes 9.7819% risk (volatility on return distribution) over the 90 days horizon. In different words, 87% of stocks are less volatile than Bioatla, and 85% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bioatla Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioatla's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bioatla, and traders can use it to determine the average amount a Bioatla's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0787
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BCAB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Bioatla is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioatla by adding it to a well-diversified portfolio.
Bioatla Fundamentals Growth
Bioatla Stock prices reflect investors' perceptions of the future prospects and financial health of Bioatla, and Bioatla fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioatla Stock performance.
| Return On Equity | -8.14 | ||||
| Return On Asset | -1.05 | ||||
| Current Valuation | 40.43 M | ||||
| Shares Outstanding | 58.79 M | ||||
| Price To Book | 2.68 X | ||||
| Price To Sales | 4.22 X | ||||
| Revenue | 11 M | ||||
| Gross Profit | (46.73 M) | ||||
| EBITDA | (73.02 M) | ||||
| Net Income | (69.78 M) | ||||
| Cash And Equivalents | 178.12 M | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 836 K | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 7.48 X | ||||
| Book Value Per Share | (0.53) X | ||||
| Cash Flow From Operations | (71.94 M) | ||||
| Earnings Per Share | (1.15) X | ||||
| Market Capitalization | 42.57 M | ||||
| Total Asset | 52.42 M | ||||
| Retained Earnings | (486.04 M) | ||||
| Working Capital | 36.69 M | ||||
About Bioatla Performance
By analyzing Bioatla's fundamental ratios, stakeholders can gain valuable insights into Bioatla's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bioatla has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bioatla has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.33) | (1.40) | |
| Return On Capital Employed | (1.95) | (2.05) | |
| Return On Assets | (1.33) | (1.40) | |
| Return On Equity | (4.89) | (4.65) |
Things to note about Bioatla performance evaluation
Checking the ongoing alerts about Bioatla for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bioatla help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioatla is way too risky over 90 days horizon | |
| Bioatla has some characteristics of a very speculative penny stock | |
| Bioatla appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 11 M. Net Loss for the year was (69.78 M) with loss before overhead, payroll, taxes, and interest of (46.73 M). | |
| Bioatla currently holds about 178.12 M in cash with (71.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: How rising interest rates impact BioAtla Inc. stock - 2025 Bull vs Bear Weekly Momentum Stock Picks - DonanmHaber |
- Analyzing Bioatla's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioatla's stock is overvalued or undervalued compared to its peers.
- Examining Bioatla's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioatla's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioatla's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bioatla's stock. These opinions can provide insight into Bioatla's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bioatla Stock analysis
When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |